[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2018 [#2]

Announcement Date
26-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- 94.64%
YoY- 9.21%
View:
Show?
Cumulative Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 321,893 302,044 295,852 257,250 240,355 158,605 101,907 21.10%
PBT 43,373 37,118 37,102 26,170 24,764 17,664 20,605 13.19%
Tax -10,369 -8,828 -8,721 -5,184 -5,559 -5,895 -5,788 10.19%
NP 33,004 28,290 28,381 20,986 19,205 11,769 14,817 14.26%
-
NP to SH 33,004 28,290 28,381 20,986 19,217 12,346 14,817 14.26%
-
Tax Rate 23.91% 23.78% 23.51% 19.81% 22.45% 33.37% 28.09% -
Total Cost 288,889 273,754 267,471 236,264 221,150 146,836 87,090 22.09%
-
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 190,284 21.55%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 3,530 3,421 6,618 4,199 6,973 6,973 5,596 -7.38%
Div Payout % 10.70% 12.10% 23.32% 20.01% 36.29% 56.49% 37.77% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 190,284 21.55%
NOSH 706,330 684,383 661,881 650,902 278,959 278,959 139,915 30.94%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 10.25% 9.37% 9.59% 8.16% 7.99% 7.42% 14.54% -
ROE 5.37% 4.86% 5.64% 9.99% 4.15% 2.77% 7.79% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 45.58 44.13 44.70 91.88 86.16 56.86 72.83 -7.50%
EPS 4.67 4.13 4.26 3.22 6.88 4.22 10.59 -12.74%
DPS 0.50 0.50 1.00 1.50 2.50 2.50 4.00 -29.26%
NAPS 0.87 0.85 0.76 0.75 1.66 1.60 1.36 -7.16%
Adjusted Per Share Value based on latest NOSH - 650,902
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 33.44 31.38 30.73 26.72 24.97 16.48 10.59 21.10%
EPS 3.43 2.94 2.95 2.18 2.00 1.28 1.54 14.26%
DPS 0.37 0.36 0.69 0.44 0.72 0.72 0.58 -7.21%
NAPS 0.6382 0.6043 0.5225 0.2181 0.481 0.4636 0.1977 21.54%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 3.03 1.62 1.37 1.30 2.25 2.04 2.65 -
P/RPS 6.65 3.67 3.06 1.41 2.61 3.59 3.64 10.55%
P/EPS 64.83 39.19 31.95 17.34 32.66 46.09 25.02 17.17%
EY 1.54 2.55 3.13 5.77 3.06 2.17 4.00 -14.69%
DY 0.17 0.31 0.73 1.15 1.11 1.23 1.51 -30.48%
P/NAPS 3.48 1.91 1.80 1.73 1.36 1.28 1.95 10.12%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 -
Price 2.49 3.15 1.41 1.08 2.03 2.14 2.40 -
P/RPS 5.46 7.14 3.15 1.18 2.36 3.76 3.30 8.74%
P/EPS 53.28 76.20 32.88 14.41 29.47 48.35 22.66 15.29%
EY 1.88 1.31 3.04 6.94 3.39 2.07 4.41 -13.23%
DY 0.20 0.16 0.71 1.39 1.23 1.17 1.67 -29.76%
P/NAPS 2.86 3.71 1.86 1.44 1.22 1.34 1.76 8.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment